7CHP
Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-06-02 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.9796 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 112.544, 171.566, 54.873 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 50.984 - 2.357 |
R-factor | 0.1947 |
Rwork | 0.193 |
R-free | 0.21980 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6m0j |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.15.2_3472) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 68.220 | 2.480 |
High resolution limit [Å] | 2.357 | 2.357 |
Number of reflections | 43632 | 4424 |
<I/σ(I)> | 13 | |
Completeness [%] | 97.3 | |
Redundancy | 13.2 | |
CC(1/2) | 0.997 | 0.808 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | 0.2M Lithium sulfate monohydrate, 0.1M HEPES, pH 7.5, 25% w/v PEG 3350 |